miR-107 was shown to negatively regulate NEAT1 expression and regulate breast cancer progression through affecting the tumor development-associated genes, including TIMP-1, PDGF-A, SERPINB2, cyclin D1, CDK4, and CPA1A in breast cancer cells. Here, TIMP1 is linked to breast carcinoma.